x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

VJOncology Podcast

The Video Journal of Oncology (VJOncology) podcast covers the latest oncology news from international experts across a view variety of solid tumors. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com

health & fitness medicine

All Episodes

11:29

CAR-T in solid tumors: advances and challenges in...

VJOncology Podcast ·

2023/02/10

Whilst CAR-T cell therapies have found considerable success in targeting hematological malignancies, major hurdles remain in the solid tumor space. Novel targets such as claudin 18.2 (CLDN18.2), and innovative strategies have led to encouraging results in solid tumors. In this podcast, we will hear from Gregory P. Botta, MD, PhD, UC San Diego Medical Center, San Diego, CA, Jon Amund Kyte, MD, PhD, University of Oslo, Oslo, Norway, Benjamin Schlechter, MD, Dana-Farber Cancer Institute, Boston, MA,

en-gb

09:48

ASCO GI 2023: Bile duct cancer updates with Ghassan...

VJOncology Podcast ·

2023/02/03

In this episode, we are joined by Professor Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center. Professor Abou-Alfa is a renowned expert in biliary tract cancer and will be sharing insights and updates from the ASCO GI Cancers Symposium 2023, including a discussion of the Phase II IMbrave 151 trial (NCT04677504). We will also hear an overview of the current state of clinical practice in the field of biliary tract cancer and thoughts on the use of molecular testing in this field.

en-gb

26:12

Breast Cancer Sessions: Highlights from SABCS 2022...

VJOncology Podcast ·

2023/01/27

The San Antonio Breast Cancer Symposium (SABCS) 2022 took place on the 6-10th of December 2022 in San Antonio, TX. Leading experts in breast cancer came together to hear the latest clinical trial data and discuss how to improve care for patients with breast cancer. In this podcast, we hear from Sara Tolaney, MD, MPH, Sarah Sammons, MD, and Paolo Tarantino, MD, of Dana-Farber Cancer Institute, Boston, MA, as they discuss the hot topics from SABCS 2022 in an exclusive roundtable discussion. Topics

en-gb

13:25

Updates in cervical cancer

VJOncology Podcast ·

2023/01/20

January is Cervical Cancer Awareness month, so for this podcast, we’ve collected the latest updates from our interviews with leading experts in cervical cancer. Dr Jamie Takayesu, MD, of the University of Michigan, Ann Arbor, MI, explains recent research into disparities in the assessment of sexual function of men and women undergoing radiotherapy for prostate cancer or cervical cancer. Professor Jyoti Mayadev, MD, of the University of California San Diego, San Diego, CA, takes us through the

en-gb

20:14

Resistance to immune checkpoint inhibitors in NSCLC

VJOncology Podcast ·

2023/01/13

In this podcast, we’ll be covering the latest updates on immune checkpoint inhibitor resistance for patients with non-small cell lung cancer (NSCLC). We’ll be hearing from Professor Benjamin Besse, MD, Gustave Roussy Institute, Villejuif, France, Dr Kishu Ranjan, PhD, Yale School of Medicine, New Haven, CT, and Dr Biagio Ricciuti, MD, Dana-Farber Cancer Institute, Boston, MA, about new developments in our understanding of mechanisms of resistance, as well as possible therapeutic options for

en-gb

12:12

Impact of race on breast cancer outcomes

VJOncology Podcast ·

2023/01/06

Breast cancer is one of the leading causes of cancer mortality, with incidence, pathology and clinical outcomes varying by geographical distribution as well as different racial and ethnic populations. Black, compared to White women with localized breast cancer have higher mortality and worse distant recurrence-free survival, which is often attributed to social determinants of health and higher prevalence of triple-negative breast cancer in black patients. In addition, racial and ethnic diversity in

en-gb

16:22

Immunotherapy updates in GI cancer

VJOncology Podcast ·

2022/12/23

Gastrointestinal (GI) cancers have a high incidence rate and is the leading cause of cancer-related mortality. Despite current combinational treatment strategies including chemotherapy, surgery, radiotherapy, and targeted therapies, survival rates remain markedly low for patients with advanced disease due to treatment resistance, rapid disease progression and metastasis, creating a strong urgency for the development of optimal therapeutic approaches. Immunotherapy is becoming increasingly

en-gb

27:41

Updates from ESMO Asia 2022

VJOncology Podcast ·

2022/12/16

The ESMO Asia 2022 congress took place on the 2nd to the 4th of December in Singapore. We heard from experts across Asia and Europe as they discussed the latest updates in oncology in the Asia-Pacific region. In this episode, we hear from Dr Tomohiro Matsuda on the epidemiology of rare cancers in Asia, Dr Avinash Khadela and Dr Annalisa Trama on how to improve outcomes for patients with head and neck cancer, and Dr Kohei Shitara, Dr Ken Kato, and Dr Teresa Macarulla on updates in gastrointestinal

en-gb

20:23

Updates in EGFR-mutant NSCLC

VJOncology Podcast ·

2022/12/02

A large proportion of patients with non-small cell lung cancer (NSCLC) have mutations in EGFR, making it a popular target for novel therapeutics. In this podcast, we hear from Prof. Charles Swanton, Dr Emilia Lim, Prof. Sanjay Popat, Dr Qing Zhou, Dr Hazel O’Sullivan, Dr Julia Rotow, and Dr Biagio Ricciuti, as they discuss some of the latest clinical trial data in this field, as well as perspectives on molecular testing and new research into the causes of EGFR-mutant lung cancer.

en-gb

05:58

UKONS 2022: cancer care in the digital age

VJOncology Podcast ·

2022/11/25

The UKONS Annual Conference took place on 11th and 12th November 2022 in Belfast, Ireland. Leading experts gave updates on the latest challenges in oncology nursing, with discussion around the conference theme ‘cancer care in the digital age’. In this podcast, we hear from UKONS President Mark Foulkes (Royal Berkshire NHS Foundation Trust) with an overview of the UKONS 2022 debate on in-person versus virtual consultations. We also speak with experts Catherine Oakley (St Guys and St Thomas NHS

en-gb

18:54

Updates in immunotherapy from SITC 2022

VJOncology Podcast ·

2022/11/18

The 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC) took place on the 8th-12th of November 2022 in Boston, MA. Leading experts discussed practice-changing trial updates and the latest news in immune-oncology. In this podcast, we hear from Prof. Judith Varner (University of California, San Diego, CA) on the combination of myeloid cell and T-cell targeting as an effective anti-tumor strategy and Dr Saman Maleki (Western University, London, Canada) on microbiome modification

en-gb

26:18

Advances in radiotherapy from ASTRO 2022

VJOncology Podcast ·

2022/11/16

The ASTRO 2022 Annual Meeting took place on the 23-26th October 2022, in San Antonio, TX. Leading experts gave updates on clinical trials in radiotherapy, as well as discussing hot topics in the field. In this podcast, we hear from several experts in the field of radiotherapy as they update us on the biggest trials and points of discussion presented at ASTRO 2022, including results from the CALLA trial (NCT03830866), unmet needs and challenges in radiotherapy, and thoughts on how artificial

en-gb

07:14

Immunotherapy Updates in Head & Neck Cancer

VJOncology Podcast ·

2022/11/04

Head and neck squamous cell carcinoma (HNSCC) is the most prevalent form of head and neck cancer and is typically associated with tobacco use and the human papillomavirus (HPV). Whilst this form of cancer has historically been associated with poor prognosis, the advent of checkpoint inhibitors such as pembrolizumab has increased overall survival in patients with PD-L1–expressing HNSCC. In this podcast, we will hear from Marcin Dzienis, MD, Gold Coast University Hospital, Southport, Australia,

en-gb

07:10

Evolving role of ctDNA in breast cancer

VJOncology Podcast ·

2022/10/28

With the advent of next-generation sequencing technologies, circulating tumor DNA (ctDNA) has now become an important player in the diagnosis, treatment, and management of breast cancer. In early breast cancer, the clearance of ctDNA is associated with improved pathological complete response following neoadjuvant therapy and may be important in treatment selection in patients with advanced disease. Continued efforts will likely lead to improvements in the use of liquid biopsy approaches and

en-gb

16:33

Updates in Immuno-Oncology from ITOC 2022

VJOncology Podcast ·

2022/10/24

The Immunotherapy of Cancer Conference (ITOC) 2022 brought together experts in the field of immuno-oncology to hear the latest findings and discuss how to advance oncology drug development and delivery. In this podcast, we hear from Prof. Mascha Binder (Martin-Luther-Universität Halle-Wittenberg, Halle, Germany) discussing whether it is beneficial to combine immunotherapy with chemotherapy and Professor Chong Xian (Harvard Medical School, Boston, MA) on the pan synergistic antitumor activity of

en-gb

09:39

ESMO 2022: Updates in Sarcoma

VJOncology Podcast ·

2022/10/14

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in sarcoma, as they discuss the biggest trials and hot topics from the meeting. Tom Wei-Wu Chen (National Taiwan University Hospital, Taipei, Taiwan), discusses biomarker analyses from the LEADER (NCT03526679) trial, which investigated

en-gb

14:36

GI Cancer Sessions: ESMO Highlights with Geoffrey Ku...

VJOncology Podcast ·

2022/10/12

Following an exciting day at the ESMO 2022 meeting in Paris, France, leading gastrointestinal cancer experts get together to share their highlights. Join Geoffrey Ku and Sam Klempner as they dissect key updates in upper GI cancer. Topics covered include updates from DESTINYGastric-02 (NCT04014075) and MOONLIGHT (NCT03647969), as well as discussions on the optimal use of immunotherapy for patients with upper GI cancers. We also hear about research into potential novel biomarkers that could help with

en-gb

20:33

Breast Cancer Sessions: Highlights from ESMO 2022...

VJOncology Podcast ·

2022/10/10

The European Society for Medical Oncology (ESMO) Annual Meeting, showcased an array of updates in breast cancer care and management, including updates on pivotal trials in the early and metastatic breast cancer settings. In this podcast, we hear from leading experts, Elisa Agostinetto and Evandro de Azambuja (Jules Bordet, Brussels, Belgium) who discuss the latest advances in breast cancer from ESMO 2022. In hormone receptor-positive HER2-negative breast cancer, overall survival results from the

en-gb

14:17

ESMO 2022: Updates in Colorectal Cancer

VJOncology Podcast ·

2022/09/30

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in colorectal cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Sartore-Bianchi discusses overcoming acquired resistance to targeted therapy in colorectal cancer, and Dr Cremolini talks on the influence of

en-gb

10:52

ESMO 2022: Updates in Breast Cancer

VJOncology Podcast ·

2022/09/26

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in breast cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Elisa Agostinetto discusses three of the biggest trials for metastatic breast cancer: TROPiCS02 (NCT03901339), MONARCH 3 (NCT02246621) and SYNERGY

en-gb

201 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown